Results 111 to 120 of about 1,241,136 (285)
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Complexity and fractal dimensions for infinite sequences with positive entropy
The complexity function of an infinite word $w$ on a finite alphabet $A$ is the sequence counting, for each non-negative $n$, the number of words of length $n$ on the alphabet $A$ that are factors of the infinite word $w$.
Mauduit, Christian +1 more
core
Correlation of the differential expression of PIK3R1 and its spliced variant, p55α, in pan‐cancer
PIK3R1 undergoes alternative splicing to generate the isoforms, p85α and p55α. By combining large patient datasets with laboratory experiments, we show that PIK3R1 spliced variants shape cancer behavior. While tumors lose the protective p85α isoform, p55α is overexpressed, changes linked to poorer survival and more pronounced in African American ...
Ishita Gupta +10 more
wiley +1 more source
Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon +4 more
wiley +1 more source
Subtype‐specific enhancer RNAs define transcriptional regulators and prognosis in breast cancers
This study employed machine learning methodologies to perform the subtype‐specific classification of RNA‐seq data sets, which are mapped on enhancers from TCGA‐derived breast cancer patients. Their integration with gene expression (referred to as ProxCReAM eRNAs) and chromatin accessibility profiles has the potential to identify lineage‐specific and ...
Aamena Y. Patel +6 more
wiley +1 more source
On the relaxation of some classes of unbounded integral functionals
Given a Borel function having convex effective domain, but not necessarily bounded or with nonempty interior, locally bounded in the relative interior of its effective domain and verifying an upper semicontinuity type assumption in its effective domain ...
Luciano Carbone, Riccardo De Arcangelis
doaj
New Approximation Formula of Digamma Function with Bounded Remainder
This study establishes the new approximation formula for the Digamma function ψ(s)=lns−12s−112ss2+θ(s ...
Mansour Mahmoud +2 more
doaj +1 more source
Solutions to Lyapunov stability problems: nonlinear systems with continuous motions
The necessary and sufficient conditions for accurate construction of a Lyapunov function and the necessary and sufficient conditions for a set to be the asymptotic stability domain are algorithmically solved for a nonlinear dynamical system with ...
Ljubomir T. Grujic
doaj +1 more source
Aldehyde dehydrogenase 1A1 (ALDH1A1) is a cancer stem cell marker in several malignancies. We established a novel epithelial cell line from rectal adenocarcinoma with unique overexpression of this enzyme. Genetic attenuation of ALDH1A1 led to increased invasive capacity and metastatic potential, the inhibition of proliferation activity, and ultimately ...
Martina Poturnajova +25 more
wiley +1 more source
Loss of the miR‐214/199a cluster is associated with recurrence in ovarian cancer. Engineered small extracellular vesicles (m214‐sEVs) elevate miR‐214‐3p/miR‐199a‐5p in tumor cells, suppress β‐catenin, TLR4, and YKT6 signaling, reprogram tumor‐derived sEV cargo, reduce chemoresistance and migration, and enhance carboplatin efficacy and survival in ...
Weida Wang +12 more
wiley +1 more source

